Clinical Trial Detail

NCT ID NCT02272790
Title A Phase II Study Comparing AZD1775 + Chemotherapy Versus Chemotherapy Alone in Patients to Treat Ovarian, Fallopian Tube, or Primary Peritoneal Cancer.
Recruitment Active, not recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors AstraZeneca
Indications

endometrial carcinoma

fallopian tube carcinoma

ovarian carcinoma

Therapies

Adavosertib + Carboplatin

Adavosertib + Gemcitabine

Adavosertib + Paclitaxel

Age Groups: adult

No variant requirements are available.